Investigating the immunosuppressive microenvironment created by Acute Myeloid Leukaemia using invariant Natural Killer T cells as a novel therapeutic approach.

De Santo, Carmela (Principal Investigator)

Immunology and Immunotherapy

1 Article

1 results

2019
MDSC targeting with Gemtuzumab ozogamicin restores T cell immunity and immunotherapy against cancers
Fultang, L., Panetti, S., Ng, M., Collins, P., Graef, S., Rizkalla, N., Booth, S., Richard, L., Noyvert, B., Shannon-Lowe, C., Middleton, G., Mussai, F. & De Santo, C., 1 Sept 2019, In: EBioMedicine. 47, p. 235-246 12 p.
Research output: Contribution to journal › Article › peer-review

Open Access
File
38 Citations (Scopus)

267 Downloads (Pure)